{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:54:51Z","timestamp":1781650491366,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mauritania has a high prevalence of chronic hepatitis B virus (HBV) and hepatitis D virus (HDV), posing a major public health burden. A comprehensive analysis of seroprevalence, transmission dynamics, and molecular epidemiology would help inform strategies for public health interventions. This study systematically reviews the published literature in the field between 1983 and 2024, employing PRISMA 2020 guidelines. Where insufficient data were available for meta-analyses on specific inquiries, summative descriptions were included. Eight studies involving 19,781 participants were included. The pooled HBsAg seroprevalence was 15.2% (95% CI: 12.8%\u201318.0%; I\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u200991.9%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u2009\n                    <jats:italic>0.0001<\/jats:italic>\n                    ) by meta-analysis. Among HBV-exposed individuals, male sex, lower education levels, and certain occupations were more commonly observed. Genotype D dominated HBV strains (50%), followed by E (36.2%), A (12%), and G (0.5%). Among 1739 HBsAg-positive individuals from five studies, the seroprevalence of anti-HDV antibodies was 21.2% (95% CI, 14.7%\u201429.4%; I\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u200994.1%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u2009\n                    <jats:italic>0.0001<\/jats:italic>\n                    ), with HDV-RNA detectable in 52.0% of cases. Occupation and geographic location were more commonly observed among HDV-infected individuals. HDV-1 was the predominant genotype (89.3%), followed by HDV-5 (10.7%). Given the dual epidemic of HBV and HDV faced by Mauritania, targeted public health strategies will be needed. This systematic review and meta-analysis outlines some of the known epidemiology, both molecular and social, to aid the focus of public health programs.\n                  <\/jats:p>","DOI":"10.1007\/s44197-026-00559-2","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:37:32Z","timestamp":1776415052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence and Molecular Epidemiology of Hepatitis B and D Viruses in Mauritania: a Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9012-3078","authenticated-orcid":false,"given":"Sidi Mohamed","family":"Cheikh Bouna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8692-2971","authenticated-orcid":false,"given":"Nabil Said","family":"Abdellah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6662-7813","authenticated-orcid":false,"given":"Habiba","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hemeyine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2325-5802","authenticated-orcid":false,"given":"Ahmed","family":"Houmeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-4940","authenticated-orcid":false,"given":"Vanessa Meier","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-6163","authenticated-orcid":false,"given":"Sayeh","family":"Ezzikouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-4870","authenticated-orcid":false,"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5666-0970","authenticated-orcid":false,"given":"Souad","family":"Aboudkhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"559_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3748\/wjg.v13.i1.14","volume":"13","author":"S Schaefer","year":"2007","unstructured":"Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol. 2007;13:14\u201321. https:\/\/doi.org\/10.3748\/wjg.v13.i1.14.","journal-title":"World J Gastroenterol"},{"key":"559_CR2","unstructured":"H\u00e9patite B. 2024 [cited 2024 Dec 15]. https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 15 Dec 2024."},{"issue":"4","key":"559_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027696","volume":"9","author":"J Si","year":"2019","unstructured":"Si J, Yu C, Guo Y, Bian Z, Meng R, Yang L, et al. Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people. BMJ Open. 2019;9(4):e027696. https:\/\/doi.org\/10.1136\/bmjopen-2018-027696.","journal-title":"BMJ Open"},{"key":"559_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"559_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100818","volume":"5","author":"P Lampertico","year":"2023","unstructured":"Lampertico P, Degasperi E, Sandmann L, Wedemeyer H, Delta Cure 2022 Working Group. Hepatitis D virus infection: pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022. JHEP Rep. 2023;5:100818. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100818.","journal-title":"JHEP Rep"},{"key":"559_CR6","unstructured":"Hepatitis D [Internet]. [cited 2025 May 12]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-d. Accessed 12 May 2025."},{"key":"559_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41575-020-0332-6","volume":"17","author":"AL Cox","year":"2020","unstructured":"Cox AL, El-Sayed MH, Kao J-H, Lazarus JV, Lemoine M, Lok AS, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17:533\u201342. https:\/\/doi.org\/10.1038\/s41575-020-0332-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"559_CR8","unstructured":"Polaris Elimination Maps \u2013 CDA Foundation [Internet]. 2024 [cited 2024 Dec 5]. https:\/\/cdafound.org\/polaris\/elimination-maps\/. Accessed 5 Dec 2024."},{"key":"559_CR9","unstructured":"World Health Organization. Global hepatitis report 2017 [Internet]. Geneva: World Health Organization; 2017 [cited 2023 Aug 19]. https:\/\/apps.who.int\/iris\/handle\/10665\/255016. Accessed 19 Aug 2023."},{"key":"559_CR10","unstructured":"Depliant-RGPH5\u20131.pdf [Internet]. [cited 2025 Apr 1]. https:\/\/ansade.mr\/wp-content\/uploads\/2024\/09\/Depliant-RGPH5-1.pdf. Accessed 1 Apr 2025."},{"key":"559_CR11","unstructured":"Nouakchott Population 2025 [Internet]. [cited 2025 Mar 15]. https:\/\/worldpopulationreview.com\/cities\/mauritania\/nouakchott. Accessed 15 Mar 2025."},{"key":"559_CR12","doi-asserted-by":"publisher","DOI":"10.48327\/mtsi.v3i4.2023.430","volume":"3","author":"F Lunel Fabiani","year":"2023","unstructured":"Lunel Fabiani F, El Bara A, Hamed CT, Le Guillou Guillemette H. H\u00e9patites Delta en Afrique: particularit\u00e9s \u00e9pid\u00e9miologiques et cliniques. Med Trop Sante Int. 2023;3:mtsi.v3i4.2023.430. https:\/\/doi.org\/10.48327\/mtsi.v3i4.2023.430.","journal-title":"Med Trop Sante Int"},{"key":"559_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"559_CR14","unstructured":"Checklist_for_Prevalence_Studies.pdf [Internet]. [cited 2025 Mar 17]. https:\/\/jbi.global\/sites\/default\/files\/2020-08\/Checklist_for_Prevalence_Studies.pdf. Accessed 17 Mar 2025."},{"key":"559_CR15","doi-asserted-by":"crossref","unstructured":"Chukiat Viwatwongkasem, Khanokporn Donjdee, Tantanut Poodphraw. Profile Likelihood Tests for Common Risk Ratios in Meta-Analysis Studies [Internet]. Open J. Stat. 2018. https:\/\/www.scirp.org\/reference\/referencespapers?referenceid=2412693.","DOI":"10.4236\/ojs.2018.86061"},{"key":"559_CR16","unstructured":"Rui WZ, Ba\u00efdy BL, N\u2019Diaye M. \u00c9tude de l\u2019infection du virus de l\u2019h\u00e9patite B en milieu scolaire de Kiffa et S\u00e9libaby, Mauritanie."},{"key":"559_CR17","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.vaccine.2021.03.011","volume":"39","author":"A El Bara","year":"2021","unstructured":"El Bara A, Pivert A, Veillon P, Ng Wing Sang C, Bollahi M, Abdel K, et al. From national HBV and HDV screenings to vaccination and treatment in healthcare workers: the Mauritanian pilot study. Vaccine. 2021;39:2274\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.011.","journal-title":"Vaccine"},{"key":"559_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0338-4535(83)80074-9","volume":"26","author":"JE Malkin","year":"1983","unstructured":"Malkin JE, Druilhe P, Courouc\u00e9 AM, Monjour L, Gentilini M. Distribution g\u00e9ographique et ethnique des sous-types d\u2019antig\u00e8nes HBs en Mauritanie. Rev Fr Transfus Immuno-H\u00e9matologie. 1983;26:591\u20137. https:\/\/doi.org\/10.1016\/S0338-4535(83)80074-9.","journal-title":"Rev Fr Transfus Immuno-H\u00e9matologie"},{"key":"559_CR19","doi-asserted-by":"publisher","unstructured":"Boushab BM, Mohamed Limame OCM, Fatim Zahra F-M, Mamoudou S, Roseline Darnycka BM, Saliou SM. Estimation of seroprevalence of HIV, hepatitis B and C virus and syphilis among blood donors in the hospital of A\u00efoun, Mauritania. Pan Afr Med J. 2017;28:118. https:\/\/doi.org\/10.11604\/pamj.2017.28.118.12465","DOI":"10.11604\/pamj.2017.28.118.12465"},{"key":"559_CR20","unstructured":"Mohamed Lemine Ould Salem, Moctar Elbou Bellamech. Prevalence and Clinico-Biological Characteristics of Viral Hepatitis B and C in Chronic Hemodialysis Patients at the National Hospital Center of Nouakchott-Mauritania [Internet]. Auctores. [cited 2024 Nov 21]. https:\/\/www.auctoresonline.org\/article\/prevalence-and-clinico-biological-characteristics-of-viral-hepatitis-b-and-c-in-chronic-hemodialysis-patients-at-the-national-hospital-center-of-nouakchott-mauritania. Accessed 21 Nov 2024."},{"key":"559_CR21","doi-asserted-by":"publisher","unstructured":"Mansour W, Malick F-ZF, Sidiya A, Ishagh E, Chekaraou MA, Veillon P, et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol [Internet]. 2012 [cited 2023 July 12];84:1186\u201398. https:\/\/doi.org\/10.1002\/jmv.23336.","DOI":"10.1002\/jmv.23336."},{"key":"559_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcv.2012.05.011","volume":"55","author":"W Mansour","year":"2012","unstructured":"Mansour W, Bollahi M-A, Hamed C-T, Brichler S, Le Gal F, Ducancelle A, et al. Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania. J Clin Virol. 2012;55:12\u20136. https:\/\/doi.org\/10.1016\/j.jcv.2012.05.011.","journal-title":"J Clin Virol"},{"issue":"92","key":"559_CR23","first-page":"83","volume":"1999","author":"BB Lo","year":"1990","unstructured":"Lo BB, Meymouna M, Boulahi MA, Tew M, Sow A, Ba A, et al. Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania. Bull Soc Pathol Exot. 1990;1999(92):83\u20134.","journal-title":"Bull Soc Pathol Exot"},{"key":"559_CR24","doi-asserted-by":"publisher","unstructured":"Lunel-Fabiani F, Mansour W, Amar AO, Aye M, Le Gal F, Malick F-ZF, et al. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study. J Infect. 2013;67:448\u201357. https:\/\/doi.org\/10.1016\/j.jinf.2013.06.008.","DOI":"10.1016\/j.jinf.2013.06.008."},{"key":"559_CR25","doi-asserted-by":"publisher","unstructured":"Le Guillou-Guillemette H, Pivert A, ElBara A, Vall M, Sang CNW, Veillon P, et al. Prevalence, clinical and virological characteristics and short-term prognosis of hepatitis delta infection among patients with HIV\/HBV in Nouakchott, Mauritania. J Viral Hepat [Internet]. 2024 [cited 2024 June 7];n\/a. https:\/\/doi.org\/10.1111\/jvh.13950.","DOI":"10.1111\/jvh.13950."},{"key":"559_CR26","unstructured":"WHO Immunization Data portal - Detail Page [Internet]. Immun. Data. [cited 2024 Nov 25]. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page. Accessed 25 Nov 2024."},{"key":"559_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014.","journal-title":"J Hepatol"},{"issue":"3","key":"559_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","volume":"73","author":"AJ Stockdale","year":"2020","unstructured":"Stockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, Martel C, et al. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J Hepatol. 2020;73(3):523\u201332. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.008.","journal-title":"J Hepatol"},{"key":"559_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-12002-1","volume":"25","author":"M Feindiri","year":"2025","unstructured":"Feindiri M, Kabbaj H, Salihoun M, Errabih I, Melloul M, Elfahime E, et al. Hepatitis B surface antigen seroprevalence in Morocco (2000\u20132024): a systematic review and meta-analysis. BMC Infect Dis. 2025;25:1607. https:\/\/doi.org\/10.1186\/s12879-025-12002-1.","journal-title":"BMC Infect Dis"},{"key":"559_CR30","unstructured":"Masson E. H\u00e9patite B en Tunisie. \u00c9pid\u00e9miologie, facteurs de risque et impact de la vaccination [Internet]. EM-Consulte. [cited 2025 Dec 23]. https:\/\/www.em-consulte.com\/article\/1288529\/hepatite-b-en-tunisie-epidemiologie-facteurs-de-ri. Accessed 23 Dec 2025."},{"key":"559_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/liv.12135","volume":"33","author":"S Ezzikouri","year":"2013","unstructured":"Ezzikouri S, Pineau P, Benjelloun S. Hepatitis B virus in the Maghreb Region: from epidemiology to prospective research. Liver Int. 2013;33:811\u20139. https:\/\/doi.org\/10.1111\/liv.12135.","journal-title":"Liver Int"},{"key":"559_CR32","doi-asserted-by":"publisher","first-page":"e992","DOI":"10.1016\/S2214-109X(17)30298-X","volume":"5","author":"AJ Stockdale","year":"2017","unstructured":"Stockdale AJ, Chaponda M, Beloukas A, Phillips RO, Matthews PC, Papadimitropoulos A, et al. Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e992-1003. https:\/\/doi.org\/10.1016\/S2214-109X(17)30298-X.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"559_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70026","volume":"45","author":"BS Wembulua","year":"2025","unstructured":"Wembulua BS, Le Gal F, Ndiaye O, Pandi MS, Akotia MK, Badiane AS, et al. Hepatitis Delta and liver disease among people living with hepatitis B with or without HIV co\u2010infection in Senegal. Liver Int. 2025;45(3):e70026. https:\/\/doi.org\/10.1111\/liv.70026.","journal-title":"Liver Int"},{"key":"559_CR34","doi-asserted-by":"publisher","unstructured":"Marino Q, Cisse ,Moussa, Gerber ,Athena\u00efs, Dolo ,Oumar, Sayon ,Sophie, Ba ,Alhassane, et al. Low hepatitis D seroprevalence in blood donors of Bamako, Mali. Infect Dis [Internet]. Taylor & Francis; 2019 [cited 2025 Apr 24];51:622\u20134. https:\/\/doi.org\/10.1080\/23744235.2019.1620963.","DOI":"10.1080\/23744235.2019.1620963."},{"key":"559_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4269\/ajtmh.17-0065","volume":"97","author":"A Jaquet","year":"2017","unstructured":"Jaquet A, Wandeler G, Tine J, Diallo MB, Manga NM, Dia NM, et al. Prevention and care of hepatitis B in Senegal; awareness and attitudes of medical practitioners. Am J Trop Med Hyg. 2017;97:389\u201395. https:\/\/doi.org\/10.4269\/ajtmh.17-0065.","journal-title":"Am J Trop Med Hyg"},{"key":"559_CR36","doi-asserted-by":"publisher","unstructured":"Konat\u00e9 A, Coulibaly HSW, Samak\u00e9 KDW, Dicko MY, Dakouo RDW, Kaya ASW, et al. Epidemiological and Serological Profile of Hepatitis B Virus in an Urban Area in Mali. Open J Gastroenterol [Internet]. Scientific Research Publishing; 2019 [cited 2025 Apr 24];9:158\u201363. https:\/\/doi.org\/10.4236\/ojgas.2019.98018.","DOI":"10.4236\/ojgas.2019.98018."},{"issue":"1","key":"559_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-025-02919-z","volume":"22","author":"JAdaS Queiroz","year":"2025","unstructured":"Queiroz JAdaS, Arruda MB, Roca TP, Ara\u00fajo A, Passos-Silva AM, de Castro e Silva E, et al. Evaluation of HDV stability under different biological sample collection and storage conditions: implications for molecular diagnosis. Virol J. 2025;22(1):383. https:\/\/doi.org\/10.1186\/s12985-025-02919-z.","journal-title":"Virol J"},{"key":"559_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","volume":"9","author":"PJ Easterbrook","year":"2024","unstructured":"Easterbrook PJ, Luhmann N, Bajis S, Min MS, Newman M, Lesi O, et al. WHO 2024 hepatitis B guidelines: an opportunity to transform care. The Lancet Gastroenterology & Hepatology. 2024;9:493\u20135. https:\/\/doi.org\/10.1016\/S2468-1253(24)00089-X.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"559_CR39","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(01)06967-7","volume":"358","author":"E Drucker","year":"2001","unstructured":"Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet. 2001;358:1989\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(01)06967-7.","journal-title":"Lancet"},{"key":"559_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/00034983.1954.11685622","volume":"48","author":"D Gall","year":"1954","unstructured":"Gall D. The chemoprophylaxis of sleeping sickness with the diamidines. Ann Trop Med Parasitol. 1954;48:242\u201358. https:\/\/doi.org\/10.1080\/00034983.1954.11685622.","journal-title":"Ann Trop Med Parasitol"},{"key":"559_CR41","unstructured":"La pand\u00e9mie de COVID-19 \u00e0 l\u2019origine du plus grand recul ininterrompu des vaccinations en trente ans [Internet]. [cited 2025 Dec 23]. https:\/\/www.who.int\/fr\/news\/item\/15-07-2022-covid-19-pandemic-fuels-largest-continued-backslide-in-vaccinations-in-three-decades. Accessed 23 Dec 2025."},{"issue":"3","key":"559_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030588","volume":"11","author":"H El Hachimi","year":"2023","unstructured":"El Hachimi H, El Alem MMM, Haimoudane E, Yebouk C, Pedersen J, Fall-Malick F-Z, et al. The first assessments of pediatric HBV immunization coverage in Mauritania and persistence of antibody titers post infant immunizations. Vaccines. 2023;11(3):588. https:\/\/doi.org\/10.3390\/vaccines11030588.","journal-title":"Vaccines"},{"key":"559_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2468-1253(25)00069-X","volume":"10","author":"L Hiebert-Suwondo","year":"2025","unstructured":"Hiebert-Suwondo L, Manning J, Tohme RA, Buti M, Kondili LA, Spearman CW, et al. A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles. Lancet Gastroenterol Hepatol. 2025;10:671\u201384. https:\/\/doi.org\/10.1016\/S2468-1253(25)00069-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"559_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/jmv.20771","volume":"79","author":"F-H Su","year":"2007","unstructured":"Su F-H, Chen J-D, Cheng S-H, Lin C-H, Liu Y-H, Chu F-Y. Seroprevalence of hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national hepatitis-B vaccination program. J Med Virol. 2007;79(2):138\u201343. https:\/\/doi.org\/10.1002\/jmv.20771.","journal-title":"J Med Virol"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-026-00559-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:16:42Z","timestamp":1781648202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-026-00559-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s44197-026-00559-2","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and meta-analysis based exclusively on previously published data and does not involve human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"During the preparation of this work, the authors used ChatGPT to reformulate certain sentences. After using this tool, the authors reviewed and corrected the content where necessary and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Generative AI in Scientific Writing"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}